- Home
- CURI vs NPCE Comparison
CURI vs NPCE Comparison
Compare CURI & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURI
- NPCE
- Stock Information
- Founded
- CURI N/A
- NPCE 1997
- Country
- CURI United States
- NPCE United States
- Employees
- CURI N/A
- NPCE N/A
- Industry
- CURI Movies/Entertainment
- NPCE Medical Specialities
- Sector
- CURI Consumer Discretionary
- NPCE Health Care
- Exchange
- CURI Nasdaq
- NPCE Nasdaq
- Market Cap
- CURI 394.5M
- NPCE 424.1M
- IPO Year
- CURI N/A
- NPCE 2021
- Fundamental
- Price
- CURI $4.82
- NPCE $10.39
- Analyst Decision
- CURI Strong Buy
- NPCE Buy
- Analyst Count
- CURI 2
- NPCE 7
- Target Price
- CURI $5.40
- NPCE $15.14
- AVG Volume (30 Days)
- CURI 952.4K
- NPCE 412.6K
- Earning Date
- CURI 08-12-2025
- NPCE 08-12-2025
- Dividend Yield
- CURI 6.64%
- NPCE N/A
- EPS Growth
- CURI N/A
- NPCE N/A
- EPS
- CURI N/A
- NPCE N/A
- Revenue
- CURI $54,223,000.00
- NPCE $84,306,000.00
- Revenue This Year
- CURI $24.74
- NPCE $21.00
- Revenue Next Year
- CURI $13.30
- NPCE $11.81
- P/E Ratio
- CURI N/A
- NPCE N/A
- Revenue Growth
- CURI N/A
- NPCE 22.05
- 52 Week Low
- CURI $0.99
- NPCE $5.45
- 52 Week High
- CURI $7.15
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- CURI 42.70
- NPCE 36.54
- Support Level
- CURI $5.20
- NPCE $10.10
- Resistance Level
- CURI $5.67
- NPCE $11.53
- Average True Range (ATR)
- CURI 0.36
- NPCE 0.66
- MACD
- CURI -0.07
- NPCE -0.00
- Stochastic Oscillator
- CURI 21.19
- NPCE 28.15
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.